178 related articles for article (PubMed ID: 8722387)
21. [Helicobacter pylori and ulcer disease: diagnosis and treatment 1995].
Kayser S; Fried M
Praxis (Bern 1994); 1996 Sep; 85(39):1197-200. PubMed ID: 8927903
[TBL] [Abstract][Full Text] [Related]
22. [Helicobacter pylori and gastroduodenal pathology. Second part: Clinical aspects and therapy].
Sobhani I; Flourié B; Lavergne A; Colimon R; Mignon M; Modigliani R; Rambaud JC
Gastroenterol Clin Biol; 1991; 15(5):412-20. PubMed ID: 2070962
[No Abstract] [Full Text] [Related]
23. Eradication rates of helicobacter pylori infection with second-line treatment: non-ulcer dyspepsia compared to peptic ulcer disease.
Chung SJ; Lee DH; Kim N; Jung SH; Kim JW; Hwang JH; Park YS; Lee KH; Jung HC; Song IS
Hepatogastroenterology; 2007 Jun; 54(76):1293-6. PubMed ID: 17629092
[TBL] [Abstract][Full Text] [Related]
24. A four-year follow-up of duodenal ulcer patients after Helicobacter pylori eradication.
Tepes B; Kavcic B; Gubina M; Krizman I
Hepatogastroenterology; 1999; 46(27):1746-50. PubMed ID: 10430336
[TBL] [Abstract][Full Text] [Related]
25. [Guidelines for the diagnosis and treatment of H. pylori infection].
Malfertheiner P
MMW Fortschr Med; 2003 Dec; 145(49):42-5. PubMed ID: 14963993
[TBL] [Abstract][Full Text] [Related]
26. Treatment of low grade gastric mucosa-associated lymphoid tissue lymphoma in stage I with Helicobacter pylori eradication. Long-term results after sequential histologic and molecular follow-up.
Montalban C; Santon A; Boixeda D; Redondo C; Alvarez I; Calleja JL; de Argila CM; Bellas C
Haematologica; 2001 Jun; 86(6):609-17. PubMed ID: 11418369
[TBL] [Abstract][Full Text] [Related]
27. Persistence of Helicobacter pylori infection in patients with peptic ulcer perforation.
Andreson H; Sillakivi T; Peetsalu M; Peetsalu A; Mikelsaar M
Scand J Gastroenterol; 2007 Mar; 42(3):324-9. PubMed ID: 17354111
[TBL] [Abstract][Full Text] [Related]
28. Cost-effectiveness of Helicobacter pylori eradication therapy in duodenal ulcer disease.
Jönsson B
Scand J Gastroenterol Suppl; 1996; 215():90-5. PubMed ID: 8722390
[TBL] [Abstract][Full Text] [Related]
29. Helicobacter pylori in solid-organ transplant recipient.
Ueda Y; Chiba T
Curr Opin Organ Transplant; 2008 Dec; 13(6):586-91. PubMed ID: 19060547
[TBL] [Abstract][Full Text] [Related]
30. Helicobacter pylori infection.
Delaney B; Moayyedi P; Forman D
Clin Evid; 2005 Jun; (13):518-34. PubMed ID: 16135272
[No Abstract] [Full Text] [Related]
31. [Helicobacter pylori in 1997].
Lassen AT; Hansen JM
Ugeskr Laeger; 1997 Jun; 159(24):3760-6. PubMed ID: 9214051
[TBL] [Abstract][Full Text] [Related]
32. Helicobacter pylori and non-malignant diseases.
Rokkas T; Simsek I; Ladas S
Helicobacter; 2007 Oct; 12 Suppl 1():20-2. PubMed ID: 17727456
[TBL] [Abstract][Full Text] [Related]
33. The influence of the eradication of Helicobacter pylori on gastric ghrelin, appetite, and body mass index in patients with peptic ulcer disease.
Jang EJ; Park SW; Park JS; Park SJ; Hahm KB; Paik SY; Sin MK; Lee ES; Oh SW; Park CY; Baik HW
J Gastroenterol Hepatol; 2008 Dec; 23 Suppl 2():S278-85. PubMed ID: 19120912
[TBL] [Abstract][Full Text] [Related]
34. Anti-Helicobacter pylori treatment in bleeding ulcers: randomized controlled trial comparing 2-day versus 7-day bismuth quadruple therapy.
Kung NN; Sung JJ; Yuen NW; Ng PW; Wong KC; Chung EC; Lim BH; Choi CH; Li TH; Ma HC; Kwok SP
Am J Gastroenterol; 1997 Mar; 92(3):438-41. PubMed ID: 9068464
[TBL] [Abstract][Full Text] [Related]
35. Guidelines in the medical treatment of Helicobacter pylori infection.
Dzieniszewski J; Jarosz M
J Physiol Pharmacol; 2006 Sep; 57 Suppl 3():143-54. PubMed ID: 17033112
[TBL] [Abstract][Full Text] [Related]
36. Long-term consequences of Helicobacter pylori eradication.
Tytgat GN
Scand J Gastroenterol Suppl; 1994; 205():38-44. PubMed ID: 7863240
[TBL] [Abstract][Full Text] [Related]
37. [Helicobacter and peptic ulcer: history, diagnosis and therapy--when, in whom and how?].
Beglinger C
Schweiz Med Wochenschr; 1994 Mar; 124(10):426-8. PubMed ID: 8153602
[TBL] [Abstract][Full Text] [Related]
38. [Causal relationship between Helicobacter pylori infection and upper gastroduodenal diseases].
Satoh K; Sugano K
Nihon Rinsho; 2001 Feb; 59(2):239-45. PubMed ID: 11218392
[TBL] [Abstract][Full Text] [Related]
39. [Indication of H. pylori eradication therapy--who should be treated?].
Miwa H; Sato N
Nihon Rinsho; 2001 Feb; 59(2):301-7. PubMed ID: 11218402
[TBL] [Abstract][Full Text] [Related]
40. Helicobacter pylori eradication therapy: indications, efficacy and safety.
Kwok A; Lam T; Katelaris P; Leong RW
Expert Opin Drug Saf; 2008 May; 7(3):271-81. PubMed ID: 18462185
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
